FDA approves wider use of AstraZeneca's Crestor

02/8/2010 | Wall Street Journal, The

AstraZeneca obtained FDA approval to promote the use of cholesterol drug Crestor to prevent cardiovascular disease in patients with normal or moderately high cholesterol levels. AstraZeneca's application was supported by a study showing a 44% reduction in the number of cardiovascular events in Crestor recipients with a high C-reactive protein level after an average of nearly two years.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC